Effects of paracetamol and fentanyl on pain control during extracorporeal shockwave lithotripsy

The comparative effects of paracetamol and fentanyl on pain control during extracorporeal shockwave lithotripsy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016072329034N1

Enrollment

102

Registered

2016-09-01

Start date

2016-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Calculus of kidney. Condition 2: Opioids and related analgesics. Calculus of kidney and ureter Opioids and related analgesics

Interventions

Intervention 1: group F receive 1 µg/kg intravenous fentanyl three minutes before ESWL(Extracorporeal shock wave lithotripsy ).When visual analogue pain scale is over 3, supplemental analgesia adminis

Treatment - Drugs

group F receive 1 µg/kg intravenous fentanyl three minutes before ESWL(Extracorporeal shock wave lithotripsy ).When visual analogue pain scale is over 3, supplemental analgesia administere to the grou

Group A receive 15 mg/kg intravenous paracetamol ten min before ESWL (Extracorporeal shock wave lithotripsy ).When visual analogue pain scale is over 3, supplemental analgesia administere to the group

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria : patients between 20 to 65 years of age;Patients with American Society of Anesthesiologists (ASA) physical status I or II ;patients having upper ureteric stones6-20mm. Exclusion criteria included: a history of chronic use of analgesics or alcohol; use any analgesic drug within 3 days before the procedure; allergy study drugs; under treatment of sedative or anti-depressant drugs; signs and symptoms of urinary tract infection,;allergy to study drugs;moderate to severe hydroureteronephrosis; presence of multiple and/or bladder and/or radiolucent stones;pregnancy; sensory neurological disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain score. Timepoint: every 10 min until the end of shock wave lithotripsy. Method of measurement: visual analogue scale (VAS).	—

Secondary

Measure	Time frame
Nausea and Vomiting. Timepoint: after ESWL procedure. Method of measurement: Side effects ranged 1to 3: one related to no nausea, two related to nausea without vomiting and nausea with vomiting is shown with score three.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshkan

Abdinezhad

dr.abdinezhad@gmail.com+98 21 8826 2239

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026